Associate Director/Director, Global Value & Access (GV&A)
Posted on Apr 6, 2021 by Acceleron Pharma Inc.
Acceleron is seeking a technically strong and innovative HEOR and market access professional who will contribute to the development of the access value and evidence plan, develop the value proposition and messages, and to bring insights on payer evidence requirements for our Clinical, R&D, and Medical Affairs teams. This individual will have responsibilities for Sotatercept, lead Pulmonary hypertension asset that has achieved BTD status in the US and PRIME designation in EMEA. In addition, individual will also be responsible for the data generation plan comprising (but not limited to) the development of an HEOR plan, publication planning, contribution to health economic model development, indirect comparison analyses and RWE evidence development for Sotatercept.
What will you be doing?
Jointly with the Global Value and Access (GV&A) Senior Director build a market access and value plan for Sotatercept from Phase II to launch
Conduct payer and market access stakeholder advisory boards in the US and Europe to drive insights into development of Sotatercept
Engage with national, regional and local payers, clinicians and HEOR experts and advisors on 1:1 meetings to drive the value and HEOR evidence plan for Sotatercept
Conduct HTA-/reimbursement-specific trial data analyses, PRO strategy development and inclusion in the trial program
Develop Sotatercept's global value and AMCP dossiers, value proposition and messages and validate messages with external stakeholders
Lead literature reviews, develop necessary RWE, conduct modeling and indirect comparison activities, develop and execute on the accompanying publication strategy
Participate in the rapid response team for Sotatercept with Global Access and Pricing portfolio lead
This position reports to the Senior Director, Global Value and Access - Sotatercept
What are we looking for?
Requires an advance degree (MS, MPH, or PhD) in health economics & outcomes research (HEOR), health services research, and/or HEOR Fellowship
6-8 years (with master's degree) and 3-5 years (with terminal degrees) of relevant HEOR and market access experience in a biotech or pharmaceutical company or related consulting services, enough to have developed a deep understanding of the global Health Technology Assessment (HTA) markets
Experience in leading the access planning and value development activities for orphan/rare diseases is preferred
Strong publication record in peer-reviewed journals and/or congresses
Experience in supporting development phase as well as launch-phase assets is preferred
Ability to operate independently in cross-functional Matrix environment with proven ability to build relationships, collaboration and teamwork across functions
Demonstration of strong strategic thinking skills, as evidenced by the ability to identify alternative scenarios and resulting implications
Strong understanding of payer environment in the US and/or Europe, including commercial payers as well as Medicare, health technologies assessment, and health policy and ability to tailor strategies to a diverse set of payer archetypes
Manages project budget to effectively generate the reimbursement and HEOR evidence to support value proposition of pulmonary assets
New product launch experience preferred
Strong written and verbal communication influencing skills